Between 1960 and 1980 various administrations attempted to deal with a rising tide of illicit drug use that was unprecedented in U.S. history. This valuable book provides a close look at the politics and bureaucracy of drug control policy during those years, showing how they changed during the presidencies of Johnson, Nixon, Ford, and Carter and how much current federal drug-control policies owe to those earlier efforts. David F. Musto, M.D., and Pamela Korsmeyer base their analysis on a unique collection of 5,000 pages of White House documents from the period, all of which are included on a searchable CD-ROM that accompanies the book. These documents reveal the intense debates that took place over drug policy. They show, for example, that staffers and cabinet officers who were charged with narcotics policy were often influenced by the cultural currents of their times, and when the public reacted in an extreme fashion to rising drug use, officials were disinclined to adopt modified policies that might have been more realistic. Musto and Korsmeyer’s investigation into the decision-making processes that shaped past drug control efforts in the United States provides essential background as creative approaches to the drug problem are sought for the future.

CD-ROM contains: Searchable drug policy documents.

A comprehensive look at the beginnings of the current drug problems in the United States Federal Drug Control: The Evolution of Policy and Practice presents an overview of the key issues and key individuals responsible for the creation of the federal government’s efforts to control illegal drugs in the United States, from 1875-2001. The book focuses special attention on federal legislation that constructed the federal drug regulatory machinery and the Supreme Court cases that interpreted these laws and their implementation. An esteemed panel of scholars, including co-editor Joseph Spillane, author of Cocaine: From Medical Marvel to Modern Menace, and William B. McAllister, author of Drug Diplomacy in the Twentieth Century: An International History, traces the internal tensions between factions favoring medicalization and criminalization throughout the 20th century, examining the difficult choices that continue to be made in this ongoing debate. The central question in the government’s response to the crisis of illicit drugs in the United States has remained the same for more than 125 years: Should the government rely on educational and treatment programs or turn to the criminal justice system for answers? Federal Drug Control examines the historic turning points of the debate, including the 19th Century origins of the controversy, legislation and subsequent Supreme Court decisions in the 20th Century, international attempts at drug control agreements, and the emergence of new illicit drugs. The book also looks at the influential figures of the debate, including Levi Nutt, Lawrence Kolb, Richard Pearson Hobson, A.G. DuMez, and Harry J. Anslinger who ran the Federal Bureau of Narcotics (FBN) for more than 30 years. Federal Drug Control examines: the history of cocaine use in the 20th Century the history of marijuana use in the 20th Century the advent of psychotropic drugs in the 1960s the origins of the Harrison Narcotic Act the federal government’s efforts to limit the pharmacy profession’s control over prescription drugs and much more! Federal Drug Control: The Evolution of Policy and Practice is an essential resource for criminologists, historians, social historians, sociologists, anthropologists, public policymakers, academics, and anyone interested in the broad issues involved in how the federal government deals with the problem of illicit drugs in the United States.

The United States and International Drug Control, 1909-1997 charts the US quest to internationalize the doctrine of drug prohibition. The study reveals the origins, motivation and methodologies as well as the recurring contradictions and inconsistencies present within the US overseas fight against the production, manufacture, trafficking and use of certain psychoactive substances. Drawing on extensive historical materials, David Bewley-Taylor uses the international career of America's first Drug Czar, Harry J. Anslinger, to explore how the US successfully exploited hegemonic superiority in 1945 to influence the philosophy of the multilateral drug control system operated by the United Nations.More than a purely historical study, the book employs an interdisciplinary approach to understanding the development, perpetuation and consequences of a US driven multilateral drug control system. Examining the contemporary UN drug control framework, the author argues that international legislation is largely ineffective.This provocative book is the first study to provide a picture of US involvement in drug control from its inception to the present day. Its wide-ranging scope makes it of interest not only to scholars of diplomatic history, US foreign Policy and international relations, but also to anyone concerned by the universal growth of the illicit drug problem.

The bestselling author of All the Shah’s Men and The Brothers tells the astonishing story of the man who oversaw the CIA’s secret drug and mind-control experiments of the 1950s and ’60s. The visionary chemist Sidney Gottlieb was the CIA’s master magician and gentlehearted torturer—the agency’s “poisoner in chief.” As head of the MK-ULTRA mind control project, he directed brutal experiments at secret prisons on three continents. He made pills, powders, and potions that could kill or maim without a trace—including some intended for Fidel Castro and other foreign leaders. He paid prostitutes to lure clients to CIA-run bordellos, where they were secretly dosed with mind-altering drugs. His experiments spread LSD across the United States, making him a hidden godfather of the 1960s counterculture. For years he was the chief supplier of spy tools used by CIA officers around the world. Stephen Kinzer, author of groundbreaking books about U.S. clandestine operations, draws on new documentary research and original interviews to bring to life one of the most powerful unknown Americans of the twentieth century. Gottlieb’s reckless experiments on “expendable” human subjects destroyed many lives, yet he considered himself deeply spiritual. He lived in a remote cabin without running water, meditated, and rose before dawn to milk his goats. During his twenty-two years at the CIA, Gottlieb worked in the deepest secrecy. Only since his death has it become possible to piece together his astonishing career at the intersection of extreme science and covert action. Poisoner in Chief reveals him as a clandestine conjurer on an epic scale.

The surprising, behind-the-scenes story of how our medicines are discovered, told by a veteran drug hunter. The search to find medicines is as old as disease, which is to say as old as the human race. Through serendipity— by chewing, brewing, and snorting—some Neolithic souls discovered opium, alcohol, snakeroot, juniper, frankincense, and other helpful substances. Ötzi the Iceman, the five-thousand-year-old hunter frozen in the Italian Alps, was found to have whipworms in his intestines and Bronze-age medicine, a worm-killing birch fungus, knotted to his leggings. Nowadays, Big Pharma conglomerates spend billions of dollars on state-of the art laboratories staffed by PhDs to discover blockbuster drugs. Yet, despite our best efforts to engineer cures, luck, trial-and-error, risk, and ingenuity are still fundamental to medical discovery. The Drug Hunters is a colorful, fact-filled narrative history of the search for new medicines from our Neolithic forebears to the professionals of today, and from quinine and aspirin to Viagra, Prozac, and Lipitor. The chapters offer a lively tour of how new drugs are actually found, the discovery strategies, the mistakes, and the rare successes. Dr. Donald R. Kirsch infuses the book with his own expertise and experiences from thirty-five years of drug hunting, whether searching for life-saving molecules in mudflats by Chesapeake Bay or as a chief science officer and research group leader at major pharmaceutical companies.

Johnson, author of the acclaimed Secret Agencies and ""an experienced overseer of intelligence"" (Foreign Affairs), here examines the present state and future challenges of American strategic intelligence.